UpToDate® : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
OST-HER2 led to significant 12-month event-free survival and demonstrated favorable overall survival trends at 1 and 2 years in recurrent, fully resected osteosarcoma and lung…
Optimizing Treatment Strategies for Localized and Advanced Genitourinary MalignanciesPresented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education.
PHILADELPHIA (January 21, 2025) — Yash Chhabra, PhD, Assistant Professor in the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, was recently…
Explore JAAOS peer-reviewed articles covering the expanse of orthopaedic medicine and representing o
subacute pain stage and progress over time because of the duration of pain experience, rather than being a specific correlate of the chronic pain stage.…
Dr. Aditya Bardia presents real-world findings on elacestrant, demonstrating prolonged real-world progression-free survival (rwPFS) in ER+/HER2- advanced breast cancer patients across all clinically relevant subgroups,…
Standardizing surgical outcomes and better training oncologic surgeons may be accomplished through the use of AI.
Breast cancer survivors who harbor BRCA gene mutation are at elevated risk for second primary cancers, according to study results.These individuals likely would benefit from…
A new study from a postbaccalaureate researcher in Mark Roth’s lab at Fred Hutch Cancer Center, Cameron Suraci, shows that microscopic worms exposed to frigid…
ine into their practice. By adopting a functional medicine approach, nurses can promote a more personalized and collaborative health care environment that can improve patient…